ReviewCurrent oncology reports2021

Receptor for Advanced Glycation End Products (RAGE) and Its Polymorphic Variants as Predictive Diagnostic and Prognostic Markers of NSCLCs: a Perspective.

Tapan K Mukherjee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.